Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, AMG Frontier Small Cap Growth Fund. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+7.53%
YTD+48.1%
Annualized+0.04%
Positioning StanceCONSTRUCTIVE
Market CapSmallCap
Digest Analysis
Quick Take
"The AMG Frontier Small Cap Growth Fund returned 7.53% in Q3 2025, lagging its benchmark due to healthcare and consumer-discretionary headwinds, but remains constructive on a small-cap rebound driven by falling interest rates."
Executive Summary
In Q3 2025, the AMG Frontier Small Cap Growth Fund (Class N) returned 7.53%, underperforming the Russell 2000 Growth Index which gained 12.19%. For the 12-month period, the fund returned 4.00% compared to the index's 13.56%. Underperformance was primarily driven by stock selection in the health care sector (including detractors Inspire Medical Systems, Ultragenyx, and Evolus) and consumer discretionary holdings (Mattel, Life Time). Technology was the primary contributing sector, led by gains in Silicon Motion and Coherent. The manager initiated new positions in Allegiant Airlines, Cognex, Unity, and Renasant Bank. Looking forward, the fund maintains a constructive outlook, believing that Federal Reserve rate cuts and improving employment will benefit small-cap corporate earnings and equity valuations.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
75%
Market Conviction
High-conviction positioning: The AMG Frontier Small Cap Growth Fund returned 7.53% in Q3 2025, lagging its benchmark due to healthcare and consumer-discretionary headwinds, but remains constructive on a small-...
85%
Growth Outlook
Market outlook remains above average conviction: The AMG Frontier Small Cap Growth Fund returned 7.53% in Q3 2025, lagging its benchmark due to healthcare and consumer-discretionary headwinds, but remains constructive on a small-...
80%
Risk Appetite
Risk appetite posture is above average conviction: The AMG Frontier Small Cap Growth Fund returned 7.53% in Q3 2025, lagging its benchmark due to healthcare and consumer-discretionary headwinds, but remains constructive on a small-...
75%
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. The AMG Frontier Small Cap Growth Fund returned 7.53% in Q3 2025, lagging its benchmark due to healthcare and consumer-discretionary headwinds, but remains constructive on a small-...
83%
Forward Guidance
Forward guidance signal: The AMG Frontier Small Cap Growth Fund returned 7.53% in Q3 2025, lagging its benchmark due to healthcare and consumer-discretionary headwinds, but remains constructive on a small-...
80%
Language Signal
Tone analysis indicates above average conviction language: The AMG Frontier Small Cap Growth Fund returned 7.53% in Q3 2025, lagging its benchmark due to healthcare and consumer-discretionary headwinds, but remains constructive on a small-...
50%
Perceived Risk
Perceived risk level is evaluated as moderate conviction. The AMG Frontier Small Cap Growth Fund returned 7.53% in Q3 2025, lagging its benchmark due to healthcare and consumer-discretionary headwinds, but remains constructive on a small-...
70%
Opportunity Density
Opportunity density index indicates above average conviction actionable entry points. The AMG Frontier Small Cap Growth Fund returned 7.53% in Q3 2025, lagging its benchmark due to healthcare and consumer-discretionary headwinds, but remains constructive on a small-...
80%
Time Horizon
Investment time horizon reflects a high conviction orientation. The AMG Frontier Small Cap Growth Fund returned 7.53% in Q3 2025, lagging its benchmark due to healthcare and consumer-discretionary headwinds, but remains constructive on a small-...